Reneo Pharmaceuticals Announces Notice of Allowance for Patent Application on REN001
October 14, 2021 08:00 ET
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo Pharmaceuticals Appoints Ashley Hall as Chief Development Officer
October 11, 2021 08:00 ET
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo Pharmaceuticals Hosting Key Opinion Leader Webinar on McArdle Disease and other Genetic Mitochondrial Myopathies
September 28, 2021 08:26 ET
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
September 09, 2021 09:12 ET
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo Pharmaceuticals Reports Second Quarter 2021 Financial Results
August 11, 2021 05:55 ET
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo Pharmaceuticals Announces First Patient Dosed in the STRIDE Study
July 28, 2021 08:00 ET
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., July 28, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
Reneo Pharmaceuticals Announces Partial Waiver of Lock-Up Restriction
July 09, 2021 08:00 ET
|
Reneo Pharmaceuticals, Inc.
SAN DIEGO, July 09, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for...
Reneo Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference
July 07, 2021 08:00 ET
|
Reneo Pharmaceuticals, Inc.
SAN DIEGO, July 07, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for...
Reneo Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices
June 29, 2021 08:00 ET
|
Reneo Pharmaceuticals, Inc.
SAN DIEGO, June 29, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for...
Reneo Pharmaceuticals Reports First Quarter 2021 Financial Results
May 20, 2021 06:00 ET
|
Reneo Pharmaceuticals, Inc.
SAN DIEGO, May 20, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for...